Uchino, Kaori <br/><br/>
Toll-like receptor 1 variation increases the risk of transplant-related mortality in hematologic malignancies.  [electronic resource] 

 -  Transplant immunology  09 2016 
 - 60-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1878-5492 
<br/><br/><label>Standard No.: </label>10.1016/j.trim.2016.06.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Bone Marrow Transplantation<br/>Child<br/>Child, Preschool<br/>Cohort Studies<br/>Female<br/>Genetic Predisposition to Disease<br/>Genotype<br/>HLA Antigens--immunology<br/>Hematologic Neoplasms--mortality<br/>Histocompatibility Testing<br/>Humans<br/>Infant<br/>Male<br/>Middle Aged<br/>Polymorphism, Single Nucleotide<br/>Retrospective Studies<br/>Risk<br/>Survival Analysis<br/>Toll-Like Receptor 1--genetics<br/>Treatment Outcome<br/>Unrelated Donors<br/>Young Adult